s-1
Showing 26 - 50 of 99
Pancreatic Cancer Trial in San Francisco, Baltimore (S-1, gemcitabine HCl)
Terminated
- Pancreatic Cancer
- S-1
- gemcitabine hydrochloride
-
San Francisco, California
- +1 more
Aug 28, 2020
Gastric Cancer Stage III Trial in Shanghai (Camrelizumab, S-1, Docetaxel)
Recruiting
- Gastric Cancer Stage III
- Camrelizumab
- +2 more
-
Shanghai, ChinaEthics Committee of Renji Hospital, School of Medicine, Shanghai
Apr 16, 2020
Pancreatic Cancer Trial in Japan (S-1, Radiation Therapy)
Completed
- Pancreatic Cancer
- S-1
- Radiation Therapy
-
Nagoya, Aichi, Japan
- +21 more
Oct 25, 2020
Gastric Adenocarcinoma Trial in Nagoya, Osaka, Tokyo (Andecaliximab, S-1, Cisplatin)
Esophagus Cancer, Esophagogastric Junction Cancer, Radiotherapy; Complications Trial in Beijing (SIB-IMRT, S-1)
Completed
- Esophagus Cancer
- +3 more
- SIB-IMRT
- S-1
-
Beijing, ChinaDepartment of Radiation Oncology, Cancer Hospital, National Canc
Jul 18, 2020
Advanced Pancreatic Cancer Trial in Shanghai (Paclitaxel liposome, S-1)
Not yet recruiting
- Advanced Pancreatic Cancer
- Paclitaxel liposome
- S-1
-
Shanghai, ChinaDepartment of Pancreatic and Hepatobiliary Surgery, Fudan Univer
Jan 1, 2020
Cholangiocarcinoma Trial in Hangzhou (radiofrequency ablation, S-1, Stent)
Completed
- Cholangiocarcinoma
- radiofrequency ablation
- +2 more
-
Hangzhou, Zhejiang, ChinaHangzhou First People's Hospital
Nov 17, 2019
Gastric Cancer Trial in Korea, Republic of (Capecitabine/cisplatin, S-1/cisplatin, Capecitabine/oxaliplatin)
Completed
- Gastric Cancer
- Capecitabine/cisplatin
- +6 more
-
Anyang, Korea, Republic of
- +13 more
Oct 22, 2020
Digestive Cancer Trial in Montpellier (S-1, Irinotecan, Oxaliplatin)
Completed
- Digestive Cancer
- S-1
- +3 more
-
Montpellier, FranceInstitut du Cancer de Montpellier - Val d'Aurelle
Aug 20, 2019
Esophageal Cancer, S-1, Radiotherapy Trial in Hangzhou (S-1, radiotherapy)
Unknown status
- Esophageal Cancer
- +2 more
- S-1
- radiotherapy
-
Hangzhou, Zhejiang, ChinaZhejiang Provincial People's Hospital
Jun 17, 2019
Stomach Tumors, Neoadjuvant Therapy, Chemoradiotherapy Trial in Beijing (radiation, drug, procedure)
Completed
- Stomach Neoplasms
- +3 more
- SIB-IMRT
- +3 more
-
Beijing, ChinaDepartment of Radiation Oncology, Cancer Hospital, Chinese Acade
Oct 15, 2019
Esophageal Squamous Cell Carcinoma Trial in Shanghai (S-1, Radiation therapy)
Completed
- Esophageal Squamous Cell Carcinoma
- S-1
- Radiation therapy
-
Shanghai, Shanghai, ChinaFudan University Cancer Center
Feb 14, 2019
Gastric Cancer Trial in Guangzhou (S-1, Oxaliplatin, Cisplatin)
Completed
- Gastric Cancer
- S-1
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jan 18, 2019
Locally Advanced or Metastatic Pancreatic Cancer Trial in Miaoli (S-1, Leucovorin(oral ), Gemcitabine)
Unknown status
- Locally Advanced or Metastatic Pancreatic Cancer
- S-1
- +6 more
-
Miaoli, TaiwanNational Institute of Cancer Research
Aug 20, 2019
Gastric Cancer With Positive Exfoliative Cancer Cells Trial (apatinib, paclitaxel, S-1)
Unknown status
- Gastric Cancer With Positive Exfoliative Cancer Cells
- apatinib
- +2 more
- (no location specified)
Oct 29, 2018
Esophagus Cancer, Stomach Cancer, Small Bowel Cancer Trial in Helsinki (S-1, Capecitabine, Oxaliplatin)
Terminated
- Esophagus Cancer
- +4 more
- S-1
- +2 more
-
Helsinki, FinlandHelsinki University Central Hospital
Aug 27, 2018
Pancreatic Cancer Trial (Albumin-bound paclitaxel, S-1, Oxaliplatin)
Unknown status
- Pancreatic Cancer
- Albumin-bound paclitaxel
- +3 more
- (no location specified)
Jan 30, 2019
Gastric Cancer Trial in Beijing (DC-CIK, S-1, Cisplatin)
Completed
- Gastric Cancer
- DC-CIK
- +2 more
-
Beijing, Beijing, ChinaCapital Medical University Cancer Center
Jul 18, 2018
Biliary Tract Cancer Trial in Osaka (Gemcitabine, S-1)
Completed
- Biliary Tract Cancer
- Gemcitabine
- S-1
-
Osaka, JapanOsaka University, Graduate School of Medicine
May 15, 2018
Gastric Cancer Trial in Guangzhou (Albumin Bound Paclitaxel, S-1)
Completed
- Gastric Cancer
- Albumin Bound Paclitaxel
- S-1
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jul 25, 2017
Gastric Cancer Trial in Beijing (Apatinib, Oxaliplatin, S-1)
Unknown status
- Gastric Cancer
- Apatinib
- +2 more
-
Beijing, Chinathe chinese PLA General Hospital
Sep 25, 2017